{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:01:34Z","timestamp":1775671294522,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Oxcarbazepine (<jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>) is a widely used antiepileptic drug for the treatment of partial seizures that was developed through structural variation of carbamazepine. Although <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content> has a lower risk of cutaneous adverse drug reactions (<jats:styled-content style=\"fixed-case\">cADR<\/jats:styled-content>s) than carbamazepine, <jats:styled-content style=\"fixed-case\">cADR<\/jats:styled-content>s ranging from maculopapular eruption (<jats:styled-content style=\"fixed-case\">MPE<\/jats:styled-content>) to the more severe Stevens\u2010Johnson syndrome and toxic epidermal necrolysis still limit the use of <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content> in some patients. A few human leukocyte antigen (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>)\u2013related genetic risk factors for carbamazepine\u2010induced <jats:styled-content style=\"fixed-case\">cADR<\/jats:styled-content>s have been identified. However, the <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010related genetic risk factors associated with <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">cADR<\/jats:styled-content>s are unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 40 patients who experienced <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">MPE<\/jats:styled-content> and 70 patients who were tolerant to <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content> treatment were included in the study. Genomic <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> was extracted from the peripheral blood of these patients, and high\u2010resolution <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content> genotyping was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010B*40:02 and <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DRB<\/jats:styled-content>1*04:03 alleles were significantly associated with <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">MPE<\/jats:styled-content> compared with the <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010tolerant group (odds ratio [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>] 4.33, p = 0.018 and <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 14.64, p = 0.003, respectively) and the general Korean population (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 4.04, p = 0.001 and <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 3.11, p = 0.019, respectively). The <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010B*15:01 genetic frequency was significantly lower in the <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">MPE<\/jats:styled-content> group compared to the <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010tolerant group (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 0.18, p = 0.016) and the Korean population (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 0.22, p = 0.030). The allele frequencies of well\u2010known <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010related risk factors for carbamazepine\u2010induced c<jats:styled-content style=\"fixed-case\">ADR<\/jats:styled-content>s (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010B*15:02, A*31:01 and B*15:11) were not different among the three groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance<\/jats:title><jats:p>This study is the first to demonstrate an association of <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010B*40:02 and <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DRB<\/jats:styled-content>1*04:03 with <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content> hypersensitivity using a large cohort of patients with <jats:styled-content style=\"fixed-case\">OXC<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">MPE<\/jats:styled-content>. These findings should be confirmed in future studies in different ethnic groups.<\/jats:p><\/jats:sec>","DOI":"10.1111\/epi.13566","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T05:56:38Z","timestamp":1474869398000},"page":"1879-1886","source":"Crossref","is-referenced-by-count":27,"title":["<scp>HLA<\/scp>\u2010B*40:02 and <scp>DRB<\/scp>1*04:03 are risk factors for oxcarbazepine\u2010induced maculopapular eruption"],"prefix":"10.1111","volume":"57","author":[{"given":"Jangsup","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae\u2010Joon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung\u2010Ah","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun\u2010Sang","family":"Sunwoo","sequence":"additional","affiliation":[{"name":"Department of Neurology Soonchunhyang University Seoul Hospital Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung\u2010Ick","family":"Byun","sequence":"additional","affiliation":[{"name":"Department of Neurology Kyung Hee University Hospital at Gangdong Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon\u2010Tae","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun\u2010Hwa","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung\u2010Il","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Neurology Healthcare System Gangnam Center Seoul National University Hospital Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki\u2010Young","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daejong","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung\u2010Sang","family":"Yu","sequence":"additional","affiliation":[{"name":"Advanced Neural Technologies Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u2010Jin","family":"Jang","sequence":"additional","affiliation":[{"name":"Advanced Neural Technologies Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kon","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology Laboratory for Neurotherapeutics Comprehensive Epilepsy Center Biomedical Research Institute Seoul National University Hospital Seoul Korea"},{"name":"Program in Neuroscience Seoul National University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2237"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.4.732"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200424040-00001"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(89)90070-3"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2000.0391"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80019-9"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.01.019"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01022.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.10.1543"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.08.010"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq537"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02766.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2005.00386.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku340"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20084"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131241"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014708107"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030066"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03318.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203040-00001"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000021"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.162"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02988.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.11.014"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-75"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2012.06.014"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2014.03.021"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13087"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02269.x"},{"key":"e_1_2_8_32_1","first-page":"40","article-title":"Comparative study of elderly\u2010onset rheumatoid arthritis and young\u2010onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA\u2010DRB1 findings","volume":"31","author":"Spinel\u2010Bejarano N","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2006.00369.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000012138"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.030593"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.13566","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.13566","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.13566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:05:54Z","timestamp":1695477954000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.13566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1111\/epi.13566"],"URL":"https:\/\/doi.org\/10.1111\/epi.13566","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]}}}